XIAOMI-W
01810
BABA-W
09988
ALI HEALTH
00241
KUAISHOU-W
01024
BIDU-SW
09888
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -47.64%327.95M | ---- | 1.35%1.18B | ---- | 21.06%626.36M | ---- | 61.13%1.16B | ---- | 6.51%517.4M |
Profit adjustment | ||||||||||
Investment loss (gain) | ---- | 195.85%111.66M | ---- | -375.91%-534.42M | ---- | -256.26%-116.5M | ---- | -4.54%-112.3M | ---- | 0.54%-32.7M |
Impairment and provisions: | ---- | -28.12%106.73M | ---- | 16.67%237.85M | ---- | 101.27%148.49M | ---- | 30.17%203.87M | ---- | -30.35%73.78M |
-Other impairments and provisions | ---- | -47.00%63.62M | ---- | 11.90%139.97M | ---- | 153.65%120.02M | ---- | 71.48%125.09M | ---- | -1.86%47.32M |
Revaluation surplus: | ---- | 43.94%-2.71M | ---- | -13.70%-10.77M | ---- | -377.09%-4.83M | ---- | 97.21%-9.47M | ---- | 100.54%1.74M |
Asset sale loss (gain): | ---- | 460.15%6.29M | ---- | -7.15%2.22M | ---- | -15.39%1.12M | ---- | 597.10%2.4M | ---- | 2.63%1.33M |
-Loss (gain) on sale of property, machinery and equipment | ---- | 460.15%6.29M | ---- | -7.15%2.22M | ---- | -15.39%1.12M | ---- | 597.10%2.4M | ---- | 2.63%1.33M |
Depreciation and amortization: | ---- | -2.74%447.02M | ---- | 40.38%851.17M | ---- | 91.08%459.62M | ---- | 52.66%606.35M | ---- | 19.53%240.54M |
-Amortization of intangible assets | ---- | -21.06%77.75M | ---- | 92.70%168.55M | ---- | 577.41%98.49M | ---- | 365.73%87.47M | ---- | 71.25%14.54M |
-Other depreciation and amortization | ---- | -45.92%8.14M | ---- | ---- | ---- | 950.72%15.05M | ---- | ---- | ---- | -36.65%1.43M |
Financial expense | ---- | -88.43%4.17M | ---- | 55.15%102.9M | ---- | -12.51%36.09M | ---- | -38.54%66.32M | ---- | 19.40%41.25M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | -58.67%-179.89M | ---- | -8.86%80.68M | ---- | -162.80%-113.38M | ---- | 121.72%88.51M | ---- | 256.47%180.54M |
Accounts receivable (increase)decrease | ---- | 119.66%205.27M | ---- | -66.64%-1.78B | ---- | -0.31%-1.04B | ---- | -115.46%-1.07B | ---- | 4.90%-1.04B |
Accounts payable increase (decrease) | ---- | -242.27%-573.36M | ---- | 100.41%1.51B | ---- | 10.19%403.02M | ---- | 51.18%751.8M | ---- | -44.40%365.75M |
Special items of business | ---- | -363.65%-239.59M | ---- | -23.28%-117.19M | ---- | -196.92%-51.67M | ---- | -3,015.57%-95.06M | ---- | 17.57%-17.4M |
Adjustment items of business operations | 10.97%743.93M | 14.53%453.14M | 294.26%104.05M | -3.43%1.63B | -28.95%670.38M | 13.54%395.65M | 80.67%-53.56M | 218.91%1.69B | 8,590.06%943.5M | 549.50%348.48M |
Net cash from operations | 10.97%743.93M | -37.91%213.56M | 294.26%104.05M | -5.02%1.51B | -28.95%670.38M | 3.90%343.97M | 80.67%-53.56M | 202.71%1.59B | 8,590.06%943.5M | 435.65%331.08M |
Cash flow from investment activities | ||||||||||
Dividend received - investment | 46.54%154.48M | 181.94%133.85M | 413.64%102.31M | 545.81%580.35M | 177.90%105.41M | 48.11%47.48M | 51.81%19.92M | 72.36%89.86M | 53.83%37.93M | 192.87%32.05M |
Sale of fixed assets | 290.49%26.39M | 342.32%24.49M | -80.27%1.01M | -78.20%7.65M | -73.42%6.76M | -77.21%5.54M | --5.14M | 199.80%35.06M | 11.38%25.43M | 11.47%24.3M |
Purchase of fixed assets | 29.97%-943.68M | 30.81%-579.28M | 54.23%-276.93M | -1.55%-2.26B | 6.87%-1.35B | 0.46%-837.18M | -191.39%-605.08M | -107.54%-2.23B | -86.94%-1.45B | -74.41%-841.05M |
Sale of subsidiaries | --42.47M | --42.47M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Acquisition of subsidiaries | ---- | ---- | ---- | 27.25%-226.44M | -37.98%-490.79M | ---226.05M | ---35.62M | -420.62%-311.26M | ---355.69M | ---- |
Recovery of cash from investments | 168.98%2.77B | 28.72%983.27M | 47.28%206.7M | -41.56%1.44B | -53.43%1.03B | -40.00%763.87M | -75.59%140.35M | -24.75%2.47B | -1.93%2.21B | 69.97%1.27B |
Cash on investment | -165.82%-4.18B | -116.01%-1.67B | -5.03%-271.2M | 15.65%-1.89B | 23.33%-1.57B | 56.87%-773.84M | 66.83%-258.21M | 37.76%-2.24B | 22.71%-2.05B | -81.57%-1.79B |
Other items in the investment business | ---- | ---- | 99.07%-200K | ---264.75M | ---- | ---- | -167.46%-21.52M | ---- | 352.06%44.43M | 352.06%44.43M |
Net cash from investment operations | 6.05%-2.13B | -4.57%-1.07B | 68.44%-238.3M | -19.52%-2.61B | -47.69%-2.27B | 19.13%-1.02B | -106.26%-755.03M | -57.38%-2.19B | -37.53%-1.54B | -85.82%-1.26B |
Net cash before financing | 13.19%-1.39B | -26.18%-853.21M | 83.40%-134.26M | -85.58%-1.1B | -169.58%-1.6B | 27.32%-676.21M | -25.73%-808.59M | 31.35%-592.34M | 47.43%-593.21M | -19.66%-930.39M |
Cash flow from financing activities | ||||||||||
New borrowing | -1.09%4.3B | 36.42%3.18B | 32.88%1.88B | -28.05%4.49B | -18.01%4.34B | -50.15%2.33B | -24.94%1.41B | 40.37%6.24B | 35.51%5.3B | 48.79%4.67B |
Refund | -19.52%-2.8B | -57.94%-2.16B | -60.96%-944.23M | 22.93%-3.08B | 21.10%-2.34B | 41.43%-1.37B | 3.24%-586.63M | -60.12%-4B | -37.16%-2.97B | -56.59%-2.33B |
Dividends paid - financing | -10.52%-587.28M | -2.80%-127.28M | -40.20%-56.61M | -55.91%-576.52M | -50.75%-531.4M | -56.40%-123.81M | -16.02%-40.38M | -45.58%-369.77M | -58.15%-352.51M | -153.65%-79.16M |
Absorb investment income | 343.88%288.03M | 389.02%285.8M | 21,177.83%85.07M | 45.01%187.37M | -47.61%64.89M | -2.59%58.44M | -98.40%399.81K | -79.25%129.22M | -45.29%123.85M | -65.98%60M |
Other items of the financing business | -1,033.62%-564.32M | -191.63%-548.48M | -12,057.28%-518.54M | -2,053.01%-370.42M | -280.10%-49.78M | 7,227.34%598.58M | -1.25%-4.27M | 27.65%-17.2M | -18.04%-13.1M | 58.90%-8.4M |
Adjustment item of financing business | --1 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net cash from financing operations | -57.46%630.99M | -57.88%630.28M | -43.35%442.93M | -67.46%643.4M | -28.87%1.48B | -35.28%1.5B | -38.04%781.86M | -13.61%1.98B | 20.11%2.09B | 30.24%2.31B |
Effect of rate | -95.03%1.49M | -106.90%-3.44M | 79.23%-1.82M | -74.47%19.37M | -65.20%29.98M | 0.16%49.83M | -311.65%-8.74M | 278.12%75.86M | 759.81%86.16M | 456.11%49.75M |
Other items affecting net cash | ---- | ---- | 0.00%1 | ---- | ---- | ---- | --1 | ---- | ---- | ---- |
Net Cash | -554.08%-757.3M | -127.18%-222.93M | 1,254.81%308.67M | -132.91%-455.88M | -107.76%-115.78M | -40.63%820.21M | -104.32%-26.73M | -2.88%1.39B | 145.53%1.49B | 38.47%1.38B |
Begining period cash | -10.37%3.77B | -10.37%3.77B | -10.37%3.77B | 53.13%4.21B | 53.13%4.21B | 53.13%4.21B | 53.13%4.21B | 101.25%2.75B | 101.25%2.75B | 101.25%2.75B |
Cash at the end | -26.82%3.02B | -30.17%3.55B | -2.26%4.08B | -10.37%3.77B | -4.69%4.13B | 21.52%5.08B | 24.02%4.18B | 53.13%4.21B | 120.70%4.33B | 77.91%4.18B |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.